國立陽明大學校長遴選委員會
社會公正人士代表推薦書
被推薦人個人資料如下：
姓
名 戚謹文
性
別
現 機 關 ( 構 ) 台北榮總教研部
名
職地
學
職
稱
電話(O)
傳 真
(O)
址
歷
■
E-Mail(O)
學
校
名
稱
科 系 組 所 名 稱學
（請填學校全銜）
生理系
博士
取 得 學 位 之 學 歷 美國紐約州立大學水牛
生物系
碩士
生物系
學士
私立輔仁大學
經 服 務 機 關 （ 構 ） 名 稱
職
稱
位
名
稱
迄
年
月
起
國立陽明大學醫學院
副院長
2005 /08
國立陽明大學藥理學研究所
所長
2002 /08 至 2008 /07
台北榮民總醫院醫學研究部
研究員
1991 /08 至 present
台北榮民總醫院一般外科
技師
1979 /05 至 1986 /07
歷 美國紐約州立大學水牛分校藥理系 博士後研究員
女
稱 教授
美國紐約州立大學水牛
請填大學（含）以上已

男
1986 /05 至 1986 /06
學
術
成 如附件
就
推薦單位：陽明大學醫學院
備註：
1. 社會公正人士，由各學院推薦或教師 15 人以上(含)之連署提名、校務會議代表
10 人以上(含)之連署提名，推薦曾任國內外大學校長、學術成就傑出、熟悉大學
事務或關心本大學發展之社會公正人士若干人。
2. 推選或推薦代表時，任一性別應占 1/3 以上。
3. 本校現職專任人員，不得被提名為校友代表及社會公正人士代表。
研究成果目錄：
論文及著述(五年內：2002-2007)
1. Liu C.-Y., Hong C.-J., Liu T.-Y., Lin K.-N., Wang P.-N., Chi C.-W., Chuang Y.-Y.,
and Liu H.-C. (2002) Lack of association between the apoE genotype and depression
in Alzheimer’s disease. J. Geriatric Psychiatry and Neurology: 15: 20-23.
2. Chiu E.-J., Lin H.-L., Chi C.-W., Liu T.-Y., and Lui W.-Y. (2002) Estrogen therapy for
hepatectomy patients with poor liver function? Medical Hypotheses 58: 516-518.
3. Chen C. -L., Chi -C. -W., and T. -Y. Liu (2002) Hydroxy radical formation and
oxidative DNA damage induced by areca quid in vivo J Toxicol Environ Health (Part
A) 65: 327-336.
4. Lui W.-Y., Chi C.-W.*, Chang Y.-F., Chu H.-W., Hsieh C.-C., Yin P.-H., Liu T.-Y.,
Ou Y.-R., and P’eng F.-K. (2002) In vivo and in vitro growth stimulation of murine
hepatoma cells by glucocorticoid. Anticancer Research 22: 1413-1422.
5. Wang J.-J., Chern Y.-T., Chang Y.-F., Liu T.-Y., and Chi C.-W.* (2002)
Dimethyladmantyl-maleimide induced in vitro and in vivo growth inhibition of human
colon cancer Colo205 cells. Anticancer Drugs 13: 533-543.
6. Lin W.-Y., Chi, C.-W., Ho Y.-J., Wu I.-C., Chung Y.-T., Chen S.-D., Chou F.-I., Kai
J.-J., Lui W.-Y., Chen T.-J., and Lin YC. (2002) Boron-lipiodol: a potential new drug
for the treatment of liver tumors. Anticancer Research 22: 3989-3992.
7. Wu C.-W., Chen G.-D., Fann C S.-J., Lee A F.-Y., Chi C.-W., Liu J. M., Weier U., and
Chen J.-Y. (2002) Clinical implications of chromosomal abnormalities in gastric
adenocarcinoma. Genes Chromosomes and Cancer 35: 219-231.
8. Wu C.-W., Chi C.-W., and Lin W.-c (2002) Gastric cancer: prognostic and diagnostic
advances. Exp. Rev. Mol. Med. 21 March,
http://www-ermm.cbcu.cam.ac.uk/02004337h.htm.
9. Wu C.-W., Lee A F.-Y., Chi C.-W., Lai C.-H., Huang C.-L., Lo S.-S., Lui W.-Y., and
Lin W.-c (2002) Clinical significance of AXL kinase family in gastric cancer.
Anticancer Research 22: 1071-1078.
10. Tsai D.-C., Hsu W.-M., Chou C.-K., Chen S.-J., Peng C.-H., Chi C.-W., Ho L.-L., Liu
J.-H., Chiou S.-H. (2002) Significant variation of the elevated nitric oxide levels in
aqueous humor from patients with different types of glaucoma. Ophthalmologica.
216:346-350.
11. Lee, H.C., Yin, P.H., Chi, C.W., Wei, Y.H. (2002) Increase of mitochondrial mass in
human fibroblasts under oxidative stress and during replicative cell senescence. J.
Biomed. Sci., 9, 517-526.
12. Lin H.-L, WY Lui W.-Y., TY Liu T.-Y., Chi C.-W.* (2003) Reversal of
Taxol-resistance in hepatoma by cyclosporin A : involvement of the PI-3 kinase-AKT
1 pathway. British J Cancer 88:973-980.
13. Tsou A.-P., Yang C.-W., Huang C.-Y. F., Yu R. C.-T., Lee Y.-C. G., Chang C.-W.,
Chen B.-R., Chung Y.-F., Fann M.-J., Chi C.-W., Chiu J.-H., and Chou C.-K (2003)
Identification of a novel cell cycle regulated gene, HURP, overexpressed in human
hepatocellular carcinoma. Oncogene 22: 298-307.
14. Wu C.-W., Li A.-F., Chi C.-W., Huang C.-J., Huang C.-L., Lui W.-Y., Lin W.-C.
(2003) Arg tyrosine kinase expression in human gastric adenocarcinoma is associated
with vessel invasion. Anticancer Res. 23(1A):205-210.
15. Yang D.-M., Huang C.-C., Lin H.-Y., Tsai D.-P., Kao L.-S., Chi C.-W., Lin C.-C.
(2003) Tracking of secretory vesicles of PC12 cells by total internal reflection
fluorescence microscopy. J Microsc. 209(Pt 3):223-227.
16. Tang D.-W., Lin S.-C., Chang K.-W., Chi C.-W., Chang C.-S., and Liu T.-Y. (2003)
Elevated expression of cyclooxygenase (COX)-2 in oral squamous cell
carcinoma-evidence for COX-2 induction by areca quid ingredients in oral keratinocytes.
J Oral Pathol Med 32: 522-529.
17. Chou F.-I., Chung H.-P., Shieh M.-S., Huang C.-W., Chung R.-J., Liu H.-M., Yang
J.-Y., Chi C.-W., Lin Y.-C., Lui W.-Y., and Kai J.-J.(2003) Synthesis and in vitro
evaluation of the phenylboric acid derivative entrapped lipiodol in neutron capture
therapy for hepatoma. Anticancer Research 23: 3955-3964.
18. Wang J.-J., Chang Y.-F., Chern Y.-T., and Chi C.-W.. (2003) Study of the in vitro and
in vivo effects of 1,6-bis[4-(4-amino-3-hydroxyphenoxy)phenyl]diamantane (DPD), a
novel cytostatic and differentiation inducing agent, on human colon cancer cells.
British J Cancer 89:1995-2003.
19. Chen J.-Y., Chi C.-W., Chen H.-L., Wan C.-P., Yang W.-C. and Yang A.-H. (2003)
TNF- renders human peritoneal mesothelial cells sensitive to anti-Fas antibody-induced
apoptosis. Nephrol Dial Transplant 18: 1741-1747.
20. Kuo C.-L., Chi C.-W., and Liu T.-Y. (2004) The anti-inflammatory potential of
berberine in vitro and in vivo. Cancer Lett 203: 127-137.
21. Yin P.-H., Lee H.-C., Chau G.-Y., Wu Y.-T., Li S.-H., Lui W.-Y., Wei Y.-H., Liu T.-Y.,
Chi C.-W.* (2004) Alteration of the copy number and deletion of mitochondrial DNA
in human hepatocellular carcinoma. British J Cancer 90: 2390-2396.
22. Liu, T, Y., Chung, Y.T., Wang, P.F., Chi, C.W., and Hsieh, L.L., (2004) Safrole-DNA
adducts in human peripheral blood - an association with areca quid chewing and
CYP2E1 polymorphisms. Mutat Res 559:59-66.
23. Lee, S-M., Tseng, L-M., Li, A.F., Liu, H.C., Liu, T.Y., and Chi, C.W.* (2004)
Polymorphism of estrogen metabolism genes and cataract. Med. Hypo 63: 494-497.
24. Ko, S.Y., Lin, S.C., Chang, K.W., Wong, Y.K., Liu, C.J., Chi, C. W. and Liu, T.Y.
(2004) Increased expression of amyloid precursor protein (APP) in oral squamous cell
carcinoma. Int. J. Cancer 111: 727-732.
25. Yin P. H, Lee H. C., Chau G.-Y., Liu T.-Y., Liu H.-C., Lui W.-Y. and Chi C.-W.* (2004)
Polymorphisms of estrogen-metabolizing genes and risk of hepatocellular carcinoma in
Taiwan females. Cancer Lett. 212:195-201.
26. Liu, C.-A., Wang, M.-J., Chi, C.-W., Wu, C.-W., and Chen, J.-Y. (2004) Overexpression
of rho effector rhotekin confers increased survival in gastric adenocarcinoma. J.
Biomed. Sci. 11: 661-670.
27. Liu, C.-A., Wang, M.-J., Chi, C.-W., Wu, C.-W., and Chen, J.-Y. (2004)
Rho/Rhotekin-mediated NF-B activation confers resistance to apoptosis. Oncogene
23:8731-8742.
28. Tang D.-W., Chang K.-W., Chi C.-W., and Liu T.-Y. (2004) Hydroxychavicol
modulates benzo[a]pyrene-induced genotoxicity through induction of dihydrodiol
dehydrogenase. Toxicology Letters 152: 235-243.
29. Hsu W.-M., Chiou S.-H., Chen S. S.-L., Shyong M.-P., Ho C.-K., Chen S.-J., Wu C.-C.,
Kung S.-H., and Chi C.-W. (2004) The HIV RNA levels of plasma and ocular fluids
in AIDS patients with ophthalmic infections. Ophthalmologica 218: 328-332.
30. Chang J.-B., Wang P.-N., Chen W.-T., Lin C.-Y., Hong C.-J., Lin K.-N., Liu T.-Y., Chi
C.-W., and Liu H.-C. (2004) ApoE e4 allele is associated with incidental hallucinations
and delusions in patients with AD. Neurology 63: 1105-1107.
31. Wu C.-W., Chi C.-W. and Huang T.-S. (2004) Elevated level of spindle checkpoint
MAD2 correlates with cellular mitotic arrest, but not with aneuploidy and
clinicopathological characteristics in gastric cancer. World J. Gastroenterol 10:
3240-3244.
32. Wang S.-Y., Wang H.-H., Chi C.-W., Chen C.-F. and Liao J.-F. (2004) Effects of
baicalein on -amyloid peptide-(25-35)-induced amnesia in mice. European J
Pharmacology 506: 55-61.
33. Wang J.-J., Chen Y.-C., Chi C.-W., Huang K.-T., and Chern Y.-T. (2004) In vitro and in
vivo growth inhibition and G1 arrest in human cancer cell lines by
diaminophenyladamantane derivatives. Anti-Cancer Drugs 15: 697-705.
34. Chang Y.-F., Chi C.-W., Chern Y.-T., and Wang J.-J. (2005) Effects of
1,6-bis[4-(4-amino-3-hydroxyphenoxy)phenyl]diamantane (DPD), a reactive oxygen
species and apoptosis inducing agent, on human leukemia cells in vitro and in vivo.
Toxicology and Applied Pharmacology 202: 1-12. (equal contribution as first author)
35. Chou F.-I., Hsieh M.-F. Chung R.-J., Liu H.-S., Chin T.-S., Lui W.-Y., Chi C.-W., and
Liu R.-S. (2005) Preparation and in vitro evaluation of radiactive calcium-phosphate
micron-sized particled for internal radiotherapy of hepatoma. Key Engineering
Materials 284-286: 859-862.
36. Wang P. N., Liu H.C., Liu T.Y., Chu A., Hong C. J., Lin K.N., Chi C.-W.* (2005)
Estrogen metabolizing gene COMT polymorphism synergistic APOE epsilon4 allele
increase the risk of Alzheimer disease. Dementia and Geriatric Cognitive Disorders
19:120-125.
37. Liu H.C., Hong C. J., Liu T.Y., Chi C.-W., and Tsai S.-J. (2005) Association analysis
for the muscarinic M1 receptor genetic polymorphisms and Alzheimer’s disease.
Dementia and Geriatric Cognitive Disorders 19:42-45.
38. Wu C.-W., Yin P.-H., Hung W.-Y., Li A. F.-Y., Li S.-H., Chi C.-W., Wei Y.-H., and
Lee H.-C. (2005) Mitochondrial DNA mutations and mitochondrial DNA depletion in
gastric cancer. Genes Chromosome and Cancer 44:19-28.
39. Liu H.C., Chi C.-W., Ko S.-Y., Wang H.-C., Hong C. J., Lin K.-N., Wang P.-N., and
Liu T.Y. (2005) Cholinesterase inhibitor affects the amyloid precursor protein isoforms
in patients with Alzheimer’s disease. Dementia and Geriatric Cognitive Disorders
19:345-348.
40. Kuo C.-L., Chi C.-W., and Liu T.-Y. (2005) Modulation of apoptosis by berberine
through inhibition of cyclooxygenase-2 and Mcl-1 expression in oral cancer cells. In
Vivo 19: 247-252.
41. Lee H.-C., Yin P.-H., Lin J.-C., Wu C.-C., Chen C.-Y., Wu C.-W., Chi C.-W., Tam
T.-N., and Wei Y.-H. (2005) Mitochondrial genome instability and mtDNA depletion
in human cancers. Ann N.Y. Acad. Sci 1042: 109-122.
42. Lo S.-S., Wu C.-W., Chi C.-W., Li A.-F., Chen J.-H. and Lui W.-Y. (2005) High CD40
expression in gastric cancer associated with expanding type histology and liver
metastasis. Hepatogastroenterology. 52:1902-1904.
43. Wu C.-W., Kao H.-L., Li A.-F., Chi C.-W. and Lin W.-C. (2005) Protein
tyrosine-phosphatase expression profiling in gastric cancer tissues. Cancer Lett.
242:95-103.
44. Yang D.-M., Lin C.-C., Lin H.-Y., Huang C.-C., Tsai D.-P., Chi C.-W. and Kao L.-S.
(2005) Dynamics of mitochondria and mitochondrial Ca 2+ near the plasma membrane of
PC12 cells. A study by multimode microscopy. Ann N.Y. Acad. Sci 1042; 163-167.
45. Wu H.-J. Chi C.-W. and Liu T.-Y. (2005) Effects of pH on nicotine-induced DNA
damage and oxidative stress. J. Toxicology Environmental Health, Part A,
68:1511–1523.
46. Chen J.-H., Wu C.-W., Kao H.-L., Chang H.-M., Li Anna F.-Y., Liu T.-Y., and Chi
C.-W., Li A.-F.,. and CHI C.-W.* (2006) Effects of COX-2 inhibitor on growth of
human gastric cancer cells and its relation to hepatocyte growth factor. Cancer letters
239: 263-270.
47. Wu C.-W., Chen J.-H., Kao H.-L., Li A.-F., Lai C.-H., Chi C.-W. and Lin W.-C. (2006)
PTPN3 and PTPN4 tyrosine phosphatase expression in human gastric adenocarcinoma.
Anticancer Res. 26(2B):1643-9.
48. Ping Y.-H., Lee H.-C., Lee J.-Y., Wu P.-H., Ho L.-K., Chi C.-W., Lu M.-F. and Wang
J.-J. (2006) Anticancer effects of low-dose 10-hydroxycamptothecin in human colon
cancer. Oncol Rep. 15:1273-9.
49. Kung S.-P., Lee C.-H., Yang A.-H., Chi C.-W., Tseng L.-M. and Wu C.-W. (2006)
Expression of c-kit, Flk-1, and Flk-2 receptors in benign and malignant tumors of
follicular epithelial origin. J Chin Med Assoc.69:74-79.
50. Tseng L.-M., Yin P.-H., Chi C.-W., Hsu C.-Y., Wu C.-W., Lee L.-M., Wei Y.-H. and
Lee H.-C. (2006) Mitochondrial DNA mutations and mitochondrial DNA depletion in
breast cancer. Genes Chromosomes Cancer. 45:629-638.
51. Wang J.-Y., Chuang H.-N., Chiu J.-H., Fu S.-L., Tsai T.-H., Tsou A.-P., Hu C.-P., Chi
C.-W., Yeh S.-F.,, Lui W.-Y., Wu C.-W. and Chou C.-K. (2006) Effects of Scutellaria
baicalensis Georgi on macrophage-hepatocyte interaction through cytokines related to
growth control of murine hepatocytes. Exp Biol Med (Maywood). 231:444-455.
52. Wang J.-J., Lee J.-Y., Chen Y.-C., Chern Y.-T. and Chi C.-W.*. (2006) The antitumor
effect of a novel differentiation inducer, 2, 2-Bis (4-(4-amino-3-hydroxyphenoxy) phenyl)
adamantane (DPA), in combinatory therapy on human colon cancer. Int J Oncol.
28:1003-1012.
53. Chang P.-C., Chi C.-W., Chau G.-Y., Li F.-Y., Tsai Y.-H., Wu J.-C. and Wu Lee Y.-H.
(2006) DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated
hepatocellular carcinoma and is involved in cell growth control. Oncogene.
30;25:1991-2003.
54. Hsu L.-S., Lee H.-C., Chau G.-Y., Yin P.-H., Chi C.-W. and Lui W.-Y. (2006) Aberrant
methylation of EDNRB and p16 genes in hepatocellular carcinoma (HCC) in Taiwan.
Oncol Rep. 15:507-511.
55. Chang S.-C., Lin J.-K., Yang S.- H., Li Anna F.-Y. and Chi C.-W*. (2006) Relationship
between genetic alterations and prognosis in sporadic colorectal cancer. International
J. Cancer 118:1721-1727.
56. Chang Y.-F. Chi C.-W. and Wang J.-J. (2006) Reactive oxygen species production is
involved in quercetin-induced apoptosis in human hepatoma cells. Nutr Cancer.
55:201-209.
57. Wu P.-H., Shen Y.-C., Wang Y.-H., Chi C.-W., and Yen J.-C. (2006) Baicalein
attenuates methamphetamine-induced loss of dopamine transporter in mouse striatum.
Toxicology. 226:238-245.
58. Liu Y.-Y., Yeh P.-H., Wang G.-J., Huang S.-W., Chi C.-W., Ho L.-K., and Pan W H.-T.
(2006) Baicalein reverses the methamphetamine-induced striatal dopaminergic
neurotoxicity in mice. J Food and Drug Analysis 14: 317-322.
59. Lee J.-L., Wang M.-J., Sudhir P.-R., Chen G.-D., Chi C.-W., and Chen J.-Y. (2007)
Osteopontin promotes integrin activation through outside-in and inside-out mechanisms:
OPN-CD44V interaction enhances survival in gastrointestinal cancer cells. Cancer
Research 67: 2089-2097.
60. Hsia C.-Y., Huo T.-I., Chiang S.-Y., Lu M.-F., Sun C.-L., Wu J.-C., Lee P.-C., Chi
C.-W. Chi, Lui W.-Y., Lee S.-D. (2007) Evaluation of interleukin-6, interleukin-10 and
human hepatocyte growth factor as tumor markers for hepatocellular carcinoma. Eur J
Surg Oncol 33: 208-212.
61. Luo J.-C., Chi C.-W., Lin H.-Y., Chang F.-Y., Lu C.-L., Chen C.-Y., Lee S.-D. (2007)
Dexamethasone inhibits epidermal growth factor-stimulated gastric epithelial cell
proliferation. J Pharmacol and Exp Ther 320:687-694.
62. Liu H.-C., Wang H.-C., Ko S.-Y., Wang P.-N., Chi C.-W., Hong C.-J., Lin K.-N., and
Liu T.-Y. (2007) Correlation between platelet amylodi precursor protein isoform ration
and cognition in Alzheimer’s disease. J Alzheimer’s Disease 11: 77-84.
63. Yang M.-H., Chang S.-Y., Chiou S.-H., Liu C.-J., Chi C.-W., Chen P.-M., Teng S.-C.,
and Wu K.-J. (2006) Overexpression of NBS1 induces epithelial-mesenchymal transition
and co-expression of NBS1 and Snail predicts metastasis of head and neck cancer.
Oncogene. 2006 Aug 28; [Epub ahead of print]
64. Lee H.-C., Hsu L.-S., Yin P.-H., Lee L.-M., and Chi C.-W. (2007) Heteroplasmic
mutation of mitochondrial DNA D-loop and 4977-bp deletion in human cancer cells
during mitochondrial DNA depletion. Mitochondrion. 7(1-2):157-63. Epub 2006 Dec 8.
65. Chau G.-Y., Lui W.-Y., Chi C.-W., Chau Y.-P., Li A.-F., Kao H.-L., and Wu C.-W.
(2007) Significance of serum hepatocyte growth factor levels in patients with
hepatocellular carcinoma undergoing hepatic resection. 2007 January 9; [Epub ahead of
print].
66. Hsieh Y.-J., Ke C.-C., Liu R.-S., Wang F.-H., Tang K.-T., Chi C.-W., Chen F.-D. and
Lee C.-H. (2007) Radioiodide imaging and treatment of ARO cancer xenograft in a
mouse model after expression of human sodium iodide symporter. Anticancer Res.
27(4B):2515-22.
67. Wu J.-W., Lin L.-C., Hung S.-C., Chi C.-W. and Tsai T.-H. (2007) Analysis of silibinin
in rat plasma and bile for hepatobiliary excretion and oral bioavailability application. J
Pharm Biomed Anal. 2007 Jul 7 [Epub ahead of print]
68. Lin H.-L., Yang M.-H., Wu C.-W., Chen P.-M., Yang Y.-P., Chu Y.-R., Kao C.-L., Ku
H.-H., Lo J.-F., Liou J.-P., Chi C.-W. and Chiou S.-H. (2007) 2-Methoxyestradiol
attenuates phosphatidylinositol 3-kinase/Akt pathway-mediated metastasis of gastric
cancer. Int J Cancer. 2007 Aug 6; [Epub ahead of print]
69. Wang Y.-W., Huo T.-I., Yang Y.-Y., Hou M.-C., Lee P.-C., Lin H.-C., Lee F.-Y., Chi
C.-W. and Lee S.-D. (2007) Correlation and comparison of the model for end-stage liver
disease, portal pressure, and serum sodium for outcome prediction in patients with liver
cirrhosis. J Clin Gastroenterol. 2007 Aug;41(7):706-12.
70. Lin H.-L., Chiou S-H., Wu C.-W., Lin W-B., Chen L.-H., Yang Y.-P., Tsai M.-L., Uen
Y.-H., Liou J.-P. and Chi C.-W. (2007) Combretastatin A4-Induced Differential
Cytotoxicity and Reduced Metastatic Ability by Inhibition of AKT Function in Human
Gastric Cancer Cells. J Pharmacol Exp Ther. 2007 Jul 23; [Epub ahead of print]
71. Huo T.-.I, Lin H.-C., Hsia C.-Y., Wu J.-C., Lee P.-C., Chi C.-W. and Lee S.-D. (2007)
The model for end-stage liver disease based cancer staging systems are better prognostic
models for hepatocellular carcinoma: a prospective sequential survey. Am J
Gastroenterol. 102(9):1920-30. Epub 2007 Jun 15.
72. Huo T.-I., Hsia C.Y-, Chu C.-J., Huang Y.-H., Lui W.-Y., Wu J.-C., Lee P.-C., Chi
C.-W. and Lee S.-D. (2007) The predictive ability of serum alpha-fetoprotein for
hepatocellular carcinoma is linked with the characteristics of the target population at
surveillance. J Surg Oncol. 95(8):645-51.
73. Huo T.-I., Huang Y.-H., Chiang J.-H., Wu J.-C., Lee P.-C., Chi C.-W. and Lee S.-D.
(2007) Survival impact of delayed treatment in patients with hepatocellular carcinoma
undergoing locoregional therapy: is there a lead-time bias? Scand J Gastroenterol.
42(4):485-92.
74. Wu C.-W., Ping Y.-H., Yen J.-C., Chang C.-Y., Wang S.-F., Yeh C.-L., Chi C.-W. and
Lee H.-C. (2007) Enhanced oxidative stress and aberrant mitochondrial biogenesis in
human neuroblastoma SH-SY5Y cells during methamphetamine induced apoptosis.
Toxicol Appl Pharmacol. 220(3):243-51. Epub 2007 Feb 7.
(Chi C.-W.* indicate corresponding author)
專利:
1. NEW USE OF DOCETAXEL FOR TREATING HEPATOMA. Patent number
WO0115675; Publication date 2001-03-08
2. USE OF DOCETAXEL FOR TREATING HEPATOCELLULAR CARCINOMA.
Patent number CA2382294; Publication date 2001-03-08
3. Pharmaceutical preparation intended for treating hepatocellular carcinoma. Patent
number CZ20020739; Publication date 2002-06-12
4. New use of docetaxel for treating hepatoma. Patent number CN1372466; Publication
date 2002-10-02
5.
6.
7.
8.
9.
10.
11.
12.
13.
USE
OF
DOCETAXEL
FOR
TREATING
HEPATOCELLULAR
CARCINOMA.Patent number. EP1214061; Publication date 2002-06-19
Use of docetaxel for treating hepatoma. Patent number US2003158249; Publication
date 2003-08-21
Use of docetaxel for treating hepatoma. Patent number EE200200087; Publication date
2003-04-15
Use of docetaxel for treating hepatoma. Patent number JP2003508427T; Publication
date 2003-03-04
VERWENDUNG VON DOCETAXEL FÜR DIE BEHANDLUNG VON
HEPATOZELLULÄRE KREBS. Patent number AT269700T; Publication date
2004-07-15
NOVA UTILIZACAO DE DOCETAXEL PARA O TRATAMENTO DO
CARCINOMA HEPATOCELULAR. Patent number PT1214061T. Publication date
2004-09-30
USE OF DOCETAXEL FOR TREATING HEPATOCELLULAR CARCINOMA.
Patent number SI1214061T; Publication date 2004-12-31
New use of docetaxel for treating hepatoma. Patent number TW589180;Publication
date 2004-06-01
林文昌,黃銓珍, 吳秋文, 戚謹文, 張久瑗, 常蘭陽. 2004. 診斷及治療胃癌
之方法. 中華民國發明專利. 中華民國證書號數: 發明第 1224623 號.
2004/12/01~ 2021/2/22